Details of the Drug Combination

General Information of Drug Combination (ID: DCD3PZ2)

Drug Combination Name
Teriparatide Teriparatide
Indication
Disease Entry Status REF
Osteoporosis Phase 1 [1]
Component Drugs Teriparatide   DMMC45B Teriparatide   DMMC45B
Peptide Peptide
2D MOL 2D MOL
3D MOL is unavailable 3D MOL is unavailable

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)
Indication(s) of Teriparatide
Disease Entry ICD 11 Status REF
Exostosis N.A. Approved [2]
Myelofibrosis 2A20.2 Approved [2]
Osteogenesis imperfecta LD24.K0 Approved [3]
Osteoporosis FB83.0 Approved [2]
Psoriatic disorder EA90 Discontinued in Phase 2 [4]
Autosomal dominant hypocalcemia 5A50.0Y Investigative [2]
Teriparatide Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Parathyroid hormone (PTH) TT6F7GZ PTHY_HUMAN Modulator [5]
------------------------------------------------------------------------------------
Indication(s) of Teriparatide
Disease Entry ICD 11 Status REF
Exostosis N.A. Approved [2]
Myelofibrosis 2A20.2 Approved [2]
Osteogenesis imperfecta LD24.K0 Approved [3]
Osteoporosis FB83.0 Approved [2]
Psoriatic disorder EA90 Discontinued in Phase 2 [4]
Autosomal dominant hypocalcemia 5A50.0Y Investigative [2]
Teriparatide Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Parathyroid hormone (PTH) TT6F7GZ PTHY_HUMAN Modulator [5]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00005006) Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
2 Teriparatide FDA Label
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4448).
4 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030730)
5 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.